Nicotinamide adenine dinucleotide phosphate oxidase activation and neuronal death after ischemic str

• 作 者: Jiamei Shen Radhika Rastogi Xiaokun Geng Yuchuan Ding
• 机 构: China-America Institute of Neuroscience,Beijing Luhe Hospital,Capital Medical University, Beijing, C
• 出 处: 中国神经再生研究（英文版）
• 发表日期: 2019年6期
• 关键词: nicotinamide adenine dinucleotide phosphate oxidase stroke nicotinamide adenine

Nicotinamide adenine dinucleotide phosphate oxidase (NOX) is a multisubunit enzyme complex that utilizes nicotinamide adenine dinucleotide phosphate to produce superoxide anions and other reactive oxygen species. Under normal circumstances, reactive oxygen species mediate a number of important cellular functions, including the facilitation of adaptive immunity. In pathogenic circumstances, however, excess reactive oxygen species generated by NOX promotes apoptotic cell death. In ischemic stroke, in particular, it has been shown that both NOX activation and derangements in glucose metabolism result in increased apoptosis. Moreover, recent studies have established that glucose, as a NOX substrate, plays a vital role in the pathogenesis of reperfusion injury. Thus, NOX inhibition has the potential to mitigate the deleterious impact of hyperglycemia on stroke. In this paper, we provide an overview of this research, coupled with a discussion of its implications for the development of NOX inhibition as a strategy for the treatment of ischemic stroke. Both inhibition using apocynin, as well as the prospect of developing more specific inhibitors based on what is now understood of the biology of NOX assembly and activation, will be highlighted in the course of our discussion.